USD 34.08
(-2.84%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 190.5 Million USD | 82.87% |
2022 | 104.17 Million USD | 33.63% |
2021 | 77.95 Million USD | 231.26% |
2020 | 23.53 Million USD | 12.11% |
2019 | 20.99 Million USD | 37.66% |
2018 | 15.24 Million USD | -0.51% |
2017 | 15.32 Million USD | 11.98% |
2016 | 13.68 Million USD | 63.75% |
2015 | 8.35 Million USD | 19301.11% |
2014 | 43.08 Thousand USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | -100.0% |
2011 | 1.43 Million USD | 35.53% |
2010 | 1.05 Million USD | 0.0% |
2009 | - USD | 0.0% |
2008 | - USD | 0.0% |
2007 | - USD | 0.0% |
2006 | - USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 191.65 Million USD | 0.61% |
2024 Q2 | 192.33 Million USD | 0.35% |
2023 Q3 | 182.18 Million USD | 7.35% |
2023 Q1 | 168.85 Million USD | 62.08% |
2023 FY | 190.5 Million USD | 82.87% |
2023 Q4 | 190.5 Million USD | 4.56% |
2023 Q2 | 169.71 Million USD | 0.51% |
2022 Q4 | 104.17 Million USD | 29.47% |
2022 FY | 104.17 Million USD | 33.63% |
2022 Q3 | 80.46 Million USD | 0.1% |
2022 Q1 | 79.13 Million USD | 1.51% |
2022 Q2 | 80.37 Million USD | 1.58% |
2021 Q1 | 20.77 Million USD | -11.73% |
2021 FY | 77.95 Million USD | 231.26% |
2021 Q2 | 76.46 Million USD | 268.13% |
2021 Q3 | 76.48 Million USD | 0.02% |
2021 Q4 | 77.95 Million USD | 1.92% |
2020 Q1 | 21.02 Million USD | 0.18% |
2020 FY | 23.53 Million USD | 12.11% |
2020 Q4 | 23.53 Million USD | -3.14% |
2020 Q3 | 24.29 Million USD | 0.16% |
2020 Q2 | 24.25 Million USD | 15.35% |
2019 FY | 20.99 Million USD | 37.66% |
2019 Q1 | 21.08 Million USD | 38.26% |
2019 Q2 | 20.61 Million USD | -2.21% |
2019 Q3 | 20.25 Million USD | -1.77% |
2019 Q4 | 20.99 Million USD | 3.65% |
2018 Q1 | 15.31 Million USD | -0.05% |
2018 Q3 | 15.28 Million USD | -0.15% |
2018 Q4 | 15.24 Million USD | -0.21% |
2018 FY | 15.24 Million USD | -0.51% |
2018 Q2 | 15.3 Million USD | -0.1% |
2017 Q2 | 13.41 Million USD | -3.3% |
2017 FY | 15.32 Million USD | 11.98% |
2017 Q4 | 15.32 Million USD | 0.03% |
2017 Q3 | 15.32 Million USD | 14.24% |
2017 Q1 | 13.87 Million USD | 1.34% |
2016 Q2 | 9.42 Million USD | 3.37% |
2016 FY | 13.68 Million USD | 63.75% |
2016 Q4 | 13.68 Million USD | 17.95% |
2016 Q3 | 11.6 Million USD | 23.16% |
2016 Q1 | 9.11 Million USD | 9.05% |
2015 Q1 | 39 Thousand USD | -9.47% |
2015 Q2 | 8.09 Million USD | 20658.97% |
2015 Q3 | 8.24 Million USD | 1.84% |
2015 Q4 | 8.35 Million USD | 1.37% |
2015 FY | 8.35 Million USD | 19301.11% |
2014 Q2 | 16.59 Thousand USD | 0.0% |
2014 Q3 | 48.95 Thousand USD | 194.95% |
2014 Q4 | 43.08 Thousand USD | -11.99% |
2014 FY | 43.08 Thousand USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2012 Q1 | 608.95 Thousand USD | -57.43% |
2012 Q2 | - USD | -100.0% |
2012 Q4 | - USD | 0.0% |
2012 FY | - USD | -100.0% |
2011 Q3 | 1.11 Million USD | 1.73% |
2011 Q2 | 1.09 Million USD | 1.74% |
2011 Q1 | 1.07 Million USD | 1.75% |
2011 FY | 1.43 Million USD | 35.53% |
2011 Q4 | 1.43 Million USD | 28.69% |
2010 FY | 1.05 Million USD | 0.0% |
2010 Q4 | 1.05 Million USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2010 Q1 | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2009 FY | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2009 Q4 | - USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2008 Q4 | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2008 FY | - USD | 0.0% |
2008 Q1 | - USD | 0.0% |
2007 Q4 | - USD | 0.0% |
2007 Q3 | - USD | 0.0% |
2007 Q1 | - USD | 0.0% |
2007 Q2 | - USD | 0.0% |
2007 FY | - USD | 0.0% |
2006 Q3 | - USD | 0.0% |
2006 FY | - USD | 0.0% |
2006 Q4 | - USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Theratechnologies Inc. | 58.96 Million USD | -223.06% |
Dynavax Technologies Corporation | 256.91 Million USD | 25.85% |
Biofrontera Inc. | 5.39 Million USD | -3428.468% |
Cronos Group Inc. | 2.53 Million USD | -7400.262% |
Sonoma Pharmaceuticals, Inc. | 608 Thousand USD | -31232.566% |
Ironwood Pharmaceuticals, Inc. | 715.53 Million USD | 73.376% |
Kala Pharmaceuticals, Inc. | 36.32 Million USD | -424.467% |
RedHill Biopharma Ltd. | 1.17 Million USD | -16140.497% |
Cumberland Pharmaceuticals Inc. | 18.42 Million USD | -933.737% |
Radius Health, Inc. | 365.31 Million USD | 47.852% |
Universe Pharmaceuticals INC | 5.48 Million USD | -3374.757% |
DURECT Corporation | 20.74 Million USD | -818.259% |
ProPhase Labs, Inc. | 21.38 Million USD | -791.029% |
Safety Shot Inc | 1.54 Million USD | -12198.592% |
Phibro Animal Health Corporation | 525.45 Million USD | 63.746% |
China SXT Pharmaceuticals, Inc. | 2.64 Million USD | -7095.665% |
Alvotech | 1.07 Billion USD | 82.287% |
Assertio Holdings, Inc. | 40.91 Million USD | -365.638% |
Supernus Pharmaceuticals, Inc. | 41.52 Million USD | -358.743% |
Rockwell Medical, Inc. | 13.43 Million USD | -1317.531% |
Sunshine Biopharma, Inc. | 657.7 Thousand USD | -28864.657% |
Procaps Group S.A. | 285.93 Million USD | 33.376% |
Intra-Cellular Therapies, Inc. | 16.93 Million USD | -1024.702% |
SCYNEXIS, Inc. | 15.08 Million USD | -1163.276% |
Aytu BioPharma, Inc. | 15.12 Million USD | -1159.184% |
Viatris Inc. | 18.12 Billion USD | 98.949% |
OptiNose, Inc. | 131.74 Million USD | -44.595% |
SIGA Technologies, Inc. | 1.46 Million USD | -12912.352% |
Tilray Brands, Inc. | 387.31 Million USD | 50.815% |
PetIQ, Inc. | 468.3 Million USD | 59.321% |
Sunshine Biopharma, Inc. | 657.7 Thousand USD | -28864.657% |
Neurocrine Biosciences, Inc. | 428.4 Million USD | 55.532% |
Guardion Health Sciences, Inc. | - USD | -Infinity% |
Alimera Sciences, Inc. | 67.39 Million USD | -182.648% |
Collegium Pharmaceutical, Inc. | 674.28 Million USD | 71.747% |
Silver Spike Investment Corp. | - USD | -Infinity% |
Shuttle Pharmaceuticals Holdings, Inc. | 1.08 Million USD | -17414.301% |
Organogenesis Holdings Inc. | 119.35 Million USD | -59.615% |
Journey Medical Corporation | 17.73 Million USD | -974.461% |
Petros Pharmaceuticals, Inc. | 8.27 Million USD | -2201.696% |
Alpha Teknova, Inc. | 30.45 Million USD | -525.458% |
Clever Leaves Holdings Inc. | 2.08 Million USD | -9028.031% |
Lifecore Biomedical, Inc. | 130.36 Million USD | -46.135% |
PainReform Ltd. | 86 Thousand USD | -221413.953% |
Cosmos Health Inc. | 12.42 Million USD | -1433.345% |
Avadel Pharmaceuticals plc | 35.38 Million USD | -438.385% |
TherapeuticsMD, Inc. | 8 Million USD | -2279.788% |
Embecta Corp. | 1.63 Billion USD | 88.373% |
Regencell Bioscience Holdings Limited | 59.8 Thousand USD | -318427.932% |
Talphera, Inc. | - USD | -Infinity% |
Pacira BioSciences, Inc. | 586.04 Million USD | 67.494% |
Incannex Healthcare Limited | 373 Thousand USD | -50972.922% |
Cyclo Therapeutics, Inc. | 1.03 Million USD | -18339.574% |
Shineco, Inc. | 29.65 Million USD | -542.363% |
Procaps Group, S.A. | 285.93 Million USD | 33.376% |
ANI Pharmaceuticals, Inc. | 315.32 Million USD | 39.586% |
Aquestive Therapeutics, Inc. | 98.82 Million USD | -92.773% |
Lantheus Holdings, Inc. | 616.94 Million USD | 69.122% |
Alvotech | 1.07 Billion USD | 82.287% |
Hempacco Co., Inc. | 13.72 Million USD | -1288.043% |
Eagle Pharmaceuticals, Inc. | 62.46 Million USD | -204.969% |
Bright Green Corporation | 1.85 Million USD | -10187.49% |
Esperion Therapeutics, Inc. | 540.94 Million USD | 64.784% |
Kamada Ltd. | 8.74 Million USD | -2077.418% |
Indivior PLC | 281.6 Million USD | 32.351% |
Evoke Pharma, Inc. | 5 Million USD | -3710.04% |
Flora Growth Corp. | 3.67 Million USD | -5087.963% |
Cyclo Therapeutics, Inc. | 1.03 Million USD | -18339.574% |
Evolus, Inc. | 126.54 Million USD | -50.54% |
HUTCHMED (China) Limited | 86.13 Million USD | -121.177% |
Amphastar Pharmaceuticals, Inc. | 623.64 Million USD | 69.453% |
Akanda Corp. | 3.99 Million USD | -4663.99% |